C-EUBCJupiter Neurosciences
micellar resveratrol, neuroinflammation, oral softgel
modulatingsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-EUBC
C-EUBCC-EUBCmicellar resveratrol, neuroinflammation, oral softgel
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Jupiter Neurosciences micellar resveratrol, neuroinflammation, oral softgel
Jupiter Neurosciences is a clinical-stage drug platform company focused on treating neuroinflammation. Its flagship product, JOTROL™, is described as a patented micellar form of resveratrol delivered as an oral softgel. The company states its long-term focus is developing a treatment for Alzheimer's disease while also pursuing treatments for rare orphan diseases.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Jupiter Neurosciences — Translational · Bottom quartile. Derived deterministically from 5 extracted project(s). Most-advanced status: phase 2. Band: translational. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic